IDO1 and TDO2, essential enzymes in the Kyn metabolic pathway, are commonly overexpressed in numerous tumor types (Figure 3), including those affecting the pancreas, breast, and brain [10, 11, 12, 13]. This evidence concerns the gene TDO2 and neoplasm.